SaveHealth explores how consumers are leveraging discount card platforms to save money while working with or around their ...

Pharmaceutical tariffs could increase drug prices and drug shortages, negatively impacting the health care system, experts warn.

Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

Most-favored-nation pricing is “founded on incorrect assumptions about where high out-of-pocket costs really come from and what it would mean for the US to adopt cost-effectiveness standards used by ...

Patent settlements accelerate the entry of generics and biosimilars, saving the health care system $422.9 billion and ...

Discover trends shaping the pharmaceutical sector. Get insights on rising prescription drug prices, supply chains, and growth ...

By a News Reporter-Staff News Editor at Health Policy and Law Daily-- A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic medicines ...

We previously reported on an uptick in the passage of state drug price transparency legislation. What follows is an update to that report. As of ...

The Federal Trade Commission (FTC) is continuing to pursue pharmaceutical manufacturers for allegedly improperly listing ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...